Spire Healthcare Group PLC · LSE:SPI
Spire Healthcare — FY2016 Earnings Presentation
33 slides from Spire Healthcare's earnings presentation, 2017
Slide 1: 2016 Financial Year Results Presentation
2016 Financial Year Results Presentation www.spirehealthcare.com
Slide 2: Disclaimer
Disclaimer Important information: forward-looking statements These materials contain certain forward-looking statements relating to the business of Spire Healthcare Group plc (the “Company”) and its subsidiaries (collectively, the “Group”), including with respect to the progress, timing and completi
Slide 3: Agenda
Agenda Executive Overview 1 Garry Watts, Chairman Financial Review 2 Simon Gordon, CFO Operating Review 3 Catherine Mason, COO Summary 4 Garry Watts, Chairman 3 www.spirehealthcare.com
Slide 4: Our comprehensive network of quality healthcare services
Executive Our comprehensive network of Overview quality healthcare services 38 10 clinics & 2 126 operating 98% of patients full service specialist cancer theatres & 1,830 rate “Excellent” hospitals care centres patient beds or “Very Good” 12,450 274,000 773,000 8.8% staff and 3,800 IP and DC patien
Slide 5: Our payor hedge
Executive Our Overview payor hedge Overall IP and DC admissions grew by 1.5% to make us the largest independent group by revenues PMI Self-pay NHS We expect PMI growth to The recent strong growth Spire’s NHS admissions be muted in the short to in the Self-pay business should continue to grow medium
Slide 6: Financial Year 2016 highlights
Executive Financial Year 2016 Overview highlights A year of solid growth, with Adjusted revenue up 5.8% and Adjusted EBITDA up 5.4% LFL (i.e. excluding disposals) revenue growth of 5.4%, with consistent comparable margins of over 18% Overall performance affected by issues at St Anthony’s, with a
Slide 7: Our senior management team
Executive Our senior Overview management team Name Position Garry Watts Executive Chairman Simon Gordon Chief Financial Officer Catherine Mason Chief Operating Officer Peter Corfield Group Commercial Director Jean Jacques de Gorter Group Medical Director Neil McCullough Group Development Director Ca
Slide 8: Financial Review
Financial Review 2 Simon Gordon, CFO 8 www.spirehealthcare.com
Slide 9: Trading headlines Financial Year 2016
Financial Trading headlines Review Financial Year 2016 Solid delivery underlying performance, St Anthony’s performance remains challenging Revenue at £926.4m up 4.7% on prior year Adjusted revenue growth up 5.8% on prior year driven by double digit Self-pay and NHS growth EBITDA at £162.0m up
Slide 10: Financial highlights Financial Year 2016: revenue
Financial Financial highlights Review Financial Year 2016 2016 2015 Growth £m £m % Group revenue 926.4 884.8 4.7% Disposals - (5.8) Group revenue excl. disposals 926.4 879.0 5.4% St Anthony’s (30.1) (31.6) Adjusted group revenues 896.3 847.4 5.8% 2016 adjusted revenue mix 2015 adjusted revenue mix 1
Slide 11: Financial highlights Financial Year 2016: EBITDA
Financial Financial highlights Review Financial Year 2016 2016 2015 Growth £m £m % Group EBITDA 162.0 160.1 1.2% Disposals - (0.3) Group EBITDA excl. disposals 162.0 159.8 1.4% St Anthony’s 1.2 (5.0) Adjusted EBITDA 163.2 154.8 5.4% 2016 2015 Growth Reported EBITDA margin 17.5% 18.1% (0.6%) Adjusted
Slide 12: Revenue and admissions growth
Financial Revenue and Review admissions growth Revenues 2016 2015 Growth % Adjusted £m £m growth % PMI 429.3 434.8 (1.3%) (0.5%) Self pay 170.4 156.2 9.1% 10.4% NHS 293.4 262.0 12.0% 13.2% Other 33.3 31.8 4.7% 5.8% Total revenues 926.4 884.8 4.7% 5.8% Admissions ’000s 2016 2015 Growth % Adjusted gro
Slide 13: NHS revenues analysis
Financial NHS revenues Review analysis Revenues 2016 2015 Growth % £m £m eReferrals 234.0 202.7 15.4% NHS local 59.4 59.3 0.2% NHS total revenues 293.4 262.0 12.0% NHS revenue mix 2016 2015 Growth % % % eReferrals 79.8% 77.4% 2.4% NHS local 20.2% 22.6% (2.4%) NHS total revenues 100.0% 100.0% - 13 ww
Slide 14: Adjusted revenue bridge by payor
Financial Adjusted revenue bridge Review by payor 2015 Rate Volume OPD Net 2016 £m £m £m £m £m £m PMI 412.1 1.8 (4.6) 0.6 (2.2) 409.9 Self pay 149.5 7.7 6.9 1.0 15.6 165.1 NHS 254.9 15.8 10.1 7.8 33.7 288.6 Other 30.9 - - 1.8 1.8 32.7 Adjusted group 847.4 25.3 12.4 11.2 48.9 896.3 revenue Adjusted =
Slide 15: Trading margin analysis – Adjusted Group
Financial Trading margin analysis – Review Adjusted Group Costs as % revenues 2016 2015 Adj Group Adj Group % % Clinical staff costs 18.3% 18.3% NHS fees 6.1% 6.0% Other direct costs 27.4% 27.3% Cost of sales 51.8% 51.6% Costs as % revenues 2016 2015 Adj Group Adj Group % % Gross margin 48.2% 48.4%
Slide 16: Taxation
Financial Taxation Review 2016 2015 (£m) (£m) Before Exceptional Total Before Exceptional Total exceptional & other exceptional & other & other items & other items items items Profit before tax 88.4 (15.2) 73.2 89.3 (15.7) 73.6 Taxation (11.8) (7.8) (19.6) (16.3) 2.7 (13.6) Profit after tax 76.6 (23
Slide 17: Comparable EPS performance
Financial Comparable EPS performance Review 2016 2015 Growth £m £m % Profit after taxation reported 53.6 60.0 (10.7%) Exceptional and other items: Exceptional items 15.2 15.7 Tax on exceptional items (0.6) (2.7) Non-recurring taxation 8.4 - Comparable profit after taxation 76.6 73.0 4.9% Comparable
Slide 18: Cash flow for the period
Financial Cash flow for the period Review 2016 2015 £m £m Operating cash flow before exceptional items and tax 186.3 166.7 Exceptional items and tax (8.9) (11.4) Operating cash flow 177.4 155.3 Net cash used in investing activities (149.9) (109.6) Net cash used in financing activities (38.5) (41.3)
Slide 19: Financial guidance for FY 2017
Financial Financial guidance for FY 2017 Review L4L Group Group Totals Group revenue 2016 (%) 94% 100% Split of Group revenue 2016 (£m) £870m £926m Total revenue 2% – 4% growth over 3% – 5% growth over 2016 L4L revenue 2016 PMI revenue 1% - 2% NHS (post impact of tariff) revenue 2% - 4% Self-pay rev
Slide 20: Operating Review
Operating Review 3 Catherine Mason, COO 20 www.spirehealthcare.com
Slide 21: Role of the Chief Operating Officer
Operating Role of the Review Chief Operating Officer Overall responsibility for day-to-day operational management Delivering Delivering Delivering excellent clinical operational asset & service outcomes excellence growth plans 21 www.spirehealthcare.com
Slide 22: Delivering excellent clinical outcomes
Operating Delivering excellent clinical Review outcomes Care Quality Commission Spire CQC Ratings – by Domain All Spire hospitals have now undergone a CQC Outstanding – 3% inspection*, with 20 formal reports published RI – 19% Of those reported, our hospitals are mainly ‘Good’ or ‘Outstanding’ a
Slide 23: Delivering operational excellence
Operating Delivering operational Review excellence Pricing outlook requires continuing focus on business processes and cost base No meaningful price growth in our PMI market in short/medium term Affordability opportunity in our Self-pay business NHS tariff reduction for the period from April 2
Slide 24: Delivering operational excellence
Operating Delivering operational Review excellence “Operational excellence” approach across all payor groups Supply chain efficiencies delivering End to end process improvement economies of scale Better processes improve customer Centralised procurement of kit satisfaction and reduce costs
Slide 25: St Anthony's – returning to anticipated growth
Operating Delivering operational Review excellence St Anthony’s – returning to anticipated growth What happened in 2016 Remedies implemented Focused on delivery of, and transition to, Senior team refreshed including new the new-build 6 theatre block Hospital Director, Matron etc Better int
Slide 26: Delivering asset and service growth plans: Spire Manchester
Operating Delivering asset and Review service growth plans New Spire Manchester hospital completed on schedule and on budget, and opened to patients in January 2017 – business ramp-up proceeding as planned Six theatres, 71 bedrooms, 5 bed CCU, 23 consulting rooms New services include hydrotherap
Slide 27: Development projects completed in FY 2016
Operating Delivering asset and Review service growth plans Other development projects completed in FY 2016 Spire St Anthony’s - New £27 million complex increasing operating capacity from four to six theatres Spire Parkway Hospital - £9 million theatre expansion and chemotherapy development with
Slide 28: Development projects for FY 2017 and FY 2018
Operating Delivering asset and Review service growth plans Development projects to be delivered in FY 2017 Spire Nottingham – Full service hospital opening April 2017, with 4 theatres, 53 inpatient beds, a day case surgical unit, 20 consulting rooms & a comprehensive diagnostic suite, including CT
Slide 29: Digital development and Spire GP
Operating Delivering asset and Review service growth plans Digital development Spire GP Rationale - delivers business efficiency & better Rationale – face to face private GP service for customer experience, by enabling patients to patients choosing not to wait for an NHS GP “self-serve” from enq
Slide 30: Summary
Summary 4 Garry Watts, Executive Chairman 30 www.spirehealthcare.com
Slide 31: Spire's future continues to be bright
Spire’s future continues Summary to be bright The medium to long term Spire proposition remains valid The need for more UK healthcare services to be provided NHS issues are set to Demand by the IS will lead to significant growth in demand continue Spire has a steady PMI business and can look forward
Slide 32: Questions
Questions 32 www.spirehealthcare.com
Slide 33: 2016 Financial Year Results Presentation
2016 Financial Year Results Presentation www.spirehealthcare.com
Spire Healthcare Group — FY2016 Earnings Presentation on 6ix